Literature DB >> 10154656

The friction cost method for measuring indirect costs of disease.

M A Koopmanschap1, F F Rutten, B M van Ineveld, L van Roijen.   

Abstract

A new approach for estimating the indirect costs of disease, which explicitly considers economic circumstances that limit production losses due to disease, is presented (the friction cost method). For the Netherlands the short-term friction costs in 1990 amount to 1.5-2.5% of net national income (NNI), depending on the extent to which short-term absence from work induces production loss and costs. The medium-term macro-economic consequences of absence from work and disability reduce NNI by an additional 0.8%. These estimates are considerably lower than estimates based on the traditional human capital approach, but they better reflect the economic impact of illness.

Entities:  

Mesh:

Year:  1995        PMID: 10154656     DOI: 10.1016/0167-6296(94)00044-5

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  294 in total

1.  Costs of employee smoking in the workplace in Scotland.

Authors:  S Parrott; C Godfrey; M Raw
Journal:  Tob Control       Date:  2000-06       Impact factor: 7.552

Review 2.  Recent advances in the methods of cost-benefit analysis in healthcare. Matching the art to the science.

Authors:  E McIntosh; C Donaldson; M Ryan
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

3.  Costs of diabetes. A methodological analysis of the literature.

Authors:  E Pagano; M Brunetti; F Tediosi; L Garattini
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

Review 4.  Handling uncertainty in cost-effectiveness models.

Authors:  A H Briggs
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 5.  Cost-of-illness studies. Useful for health policy?

Authors:  M A Koopmanschap
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

6.  How to calculate indirect costs in economic evaluations.

Authors:  W B Brouwer; M A Koopmanschap
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

7.  A practical guide for calculating indirect costs of disease.

Authors:  M A Koopmanschap; F F Rutten
Journal:  Pharmacoeconomics       Date:  1996-11       Impact factor: 4.981

Review 8.  Employers' benefits from workers' health insurance.

Authors:  Ellen O'Brien
Journal:  Milbank Q       Date:  2003       Impact factor: 4.911

9.  Standardisation of costs: the Dutch Manual for Costing in economic evaluations.

Authors:  Jan B Oostenbrink; Marc A Koopmanschap; Frans F H Rutten
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 10.  The humanistic and economic burden of systemic lupus erythematosus : a systematic review.

Authors:  Rachel Meacock; Nicola Dale; Mark J Harrison
Journal:  Pharmacoeconomics       Date:  2013-01       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.